Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record.

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care?

Open access
Yan, Tristan D., Morris, David L. · 2008 · Annals of Surgery

Abstract

BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been demonstrated to have an improved survival over systemic chemotherapy for patients with colorectal peritoneal carcinomatosis (CRPC) in a randomized controlled trial. Despite the increasing clinical evidence, controversies still exist regarding the standard treatment for these patients. METHODS: Between January 1997 and October 2007, 50 patients with isolated CRPC underwent CRS and HIPEC at the St. George Hospital, Sydney. All patients underwent preoperative chest, abdominal and pelvic computed tomography scans, and positron emission tomography. All clinicopathologic and treatment-related data were obtained prospectively and computed in univariate and multivariate analyses to determine their prognostic significance for overall survival. RESULTS: The mean age at the time of CRS was 55 (SD = 14) years. There were 19 (38%) male patients. The overall median survival was 29 months (range 1-102) with a 3-year survival rate of 39%. Three clinicopathologic factors were found to be significant for overall survival: tumor differentiation (P < 0.001), peritoneal cancer index (P = 0.021), and completeness of cytoreduction (P < 0.001). In the multivariate analysis of overall survival, 2 factors were identified to be independently associated with an improved survival: well-differentiated tumor (P = 0.045) and complete cytoreduction (P = 0.023). CONCLUSIONS: CRPC patients with low tumor volume, well/moderately differentiated tumors and complete cytoreduction may potentially benefit from the combined treatment. The combined treatment for patients with isolated colorectal peritoneal carcinomatosis should be considered to be the current standard of care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e31818a15b5

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. Sugarbaker, 1995, Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy., Ann Surg, 221, 124, 10.1097/00000658-199502000-00002 · doi:10.1097/00000658-199502000-00002
  2. Verwaal, 2003, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer., J Clin Oncol, 21, 3737, 10.1200/JCO.2003.04.187 · DOI · Paper page
  3. Glehen, 2004, Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study., J Clin Oncol, 22, 3284, 10.1200/JCO.2004.10.012 · DOI · Paper page
  4. Gomes da Silva, 2006, Analysis of 10 prognostic factors in 70 patients having complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer., Am J Coll Surg, 203, 878, 10.1016/j.jamcollsurg.2006.08.024 · doi:10.1016/j.jamcollsurg.2006.08.024
  5. Verwaal, 2005, Long-term survival of peritoneal carcinomatosis of colorectal origin., Ann Surg Oncol, 12, 65, 10.1007/s10434-004-1167-z · doi:10.1007/s10434-004-1167-z
  6. Glehen, 2004, Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin., Br J Surg, 91, 747, 10.1002/bjs.4473 · DOI
  7. Elias, 2006, Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery., Gastroenterol Clin Bio, 30, 1200, 10.1016/S0399-8320(06)73512-6 · DOI · Paper page
  8. Shen, 2004, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma., Ann Surg Oncol, 11, 178, 10.1245/ASO.2004.05.009 · doi:10.1245/aso.2004.05.009
  9. Pilati, 2003, Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma., Ann Surg Oncol, 10, 508, 10.1245/ASO.2003.08.004 · doi:10.1245/aso.2003.08.004
  10. Yan, 2006, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis., J Clin Oncol, 24, 4011, 10.1200/JCO.2006.07.1142 · DOI · Paper page
  11. Yan, 2006, Peritoneal carcinomatosis from colorectal carcinoma—standard of care., Ann Surg, 224, 623
  12. Jacquet, 1996, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis., Cancer Treat Res, 82, 359, 10.1007/978-1-4613-1247-5_23 · DOI · Paper page
  13. Sugarbaker, 1995, Peritonectomy procedures., Ann Surg, 221, 29, 10.1097/00000658-199501000-00004 · DOI · Paper page
  14. Verwaal, 2004, Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy., Br J Surg, 91, 739, 10.1002/bjs.4516 · doi:10.1002/bjs.4516
  15. Sugarbaker, 1996, Peritoneal carcinomatosis from adenocarcinoma of the colon., World J Surg, 20, 585, 10.1007/s002689900091 · doi:10.1007/s002689900091
  16. Pestieau, 2000, Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management., Dis Col Rect, 43, 1341, 10.1007/BF02236627 · DOI · Paper page
  17. Carmignani, 2004, The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer., Eur J Surg Oncol, 30, 391, 10.1016/j.ejso.2004.01.017 · doi:10.1016/j.ejso.2004.01.017
  18. Elias, 2001, Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy., Cancer, 92, 71, 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9 · DOI · Paper page
  19. Hadi, 2006, Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy., ANZ J Surg, 76, 156, 10.1111/j.1445-2197.2006.03579.x · doi:10.1111/j.1445-2197.2006.03579.x
  20. Shehata, 2006, Peritoneal carcinomatosis from colorectal cancer and small bowel cancer treated with peritonectomy., ANZ J Surg, 76, 467, 10.1111/j.1445-2197.2006.03749.x · doi:10.1111/j.1445-2197.2006.03749.x
  21. Yan, 2006, Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis—Non-mucinous tumor associated with an improved survival., Eur J Surg Oncol, 32, 1119, 10.1016/j.ejso.2006.06.007 · DOI
  22. Kecmanovic, 2005, Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy., Eur J Surg Oncol, 31, 147, 10.1016/j.ejso.2004.09.021 · doi:10.1016/j.ejso.2004.09.021
  23. Portilla, 1999, Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features., World J Surg, 23, 23, 10.1007/s002689900560 · doi:10.1007/s002689900560
  24. Gomes da Silva, 2005, Limited survival in the treatment of carcinomatosis from rectal cancer., Dis Col Rect, 48, 2258, 10.1007/s10350-005-0189-3 · doi:10.1007/s10350-005-0189-3
  25. Glehen, 2003, Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study., J Clin Oncol, 21, 799, 10.1200/JCO.2003.06.139 · doi:10.1200/jco.2003.06.139
  26. Loggie, 2000, Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin., Am Surg, 66, 561, 10.1177/000313480006600607 · doi:10.1177/000313480006600607
  27. Shen, 2003, Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis., Arch Surg, 138, 26, 10.1001/archsurg.138.1.26 · doi:10.1001/archsurg.138.1.26
  28. Culliford, 2001, Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer., Ann Surg Oncol, 8, 787, 10.1007/s10434-001-0787-9 · doi:10.1007/s10434-001-0787-9
  29. Elias, 2004, Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials., Ann Surg Oncol, 11, 518, 10.1245/ASO.2004.09.008 · DOI
  30. Esquivel, 2007, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the management of peritoneal surface malignancies of colonic origin: A Consensus Statement from the Peritoneal Surface Oncology Group., Ann Surg Oncol, 14, 128, 10.1245/s10434-006-9185-7 · doi:10.1245/s10434-006-9185-7

Cited by

See all 191

Metadata

Authors
Yan, T. D., & Morris, D. L.
Venue
Annals of Surgery
Published
2008-11
Volume
248
Issue
5
Pages
829-835
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2019028928
Cited by
191
References
0
FWCI
12.28
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care? https://app.cochat.ai/papers/10.1097/sla.0b013e31818a15b5
The paper
Yan, T. D., & Morris, D. L. (2008). Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Isolated Colorectal Peritoneal Carcinomatosis: Experimental Therapy or Standard of Care? Annals of Surgery. https://doi.org/10.1097/sla.0b013e31818a15b5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.